title: Use of nafarelin to investigate the pathophysiology of the polycystic ovary syndrome.
abstract: Although gonadotropin releasing hormone analog therapy successfully suppresses gonadotropin secretion and excess ovarian androgen production, it does not break the cycle of disordered hormonal patterns that perpetuates the syndrome.
authors.affiliation: Academic Department of Obstetrics and Gynaecology, Royal Free Hospital School of Medicine, London, England.
authors.forename: R W
authors.initials: RW
authors.lastname: Shaw
mesh_terms: D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D017274:Nafarelin; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D017274:Nafarelin; D007987:Gonadotropin-Releasing Hormone